Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis

NCT00334672 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

288

Enrollment

OTHER

Sponsor class

Conditions

Nonneoplastic Condition

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: dexamethasone
DRUG: etoposide
DRUG: methotrexate
DRUG: mycophenolate mofetil
DRUG: therapeutic hydrocortisone
OTHER: laboratory biomarker analysis
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: biopsy

Sponsor

Children's Cancer and Leukaemia Group